C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/427 (2006.01) A61P 35/00 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2579130
The present invention relates to compounds of the formula (I) which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
L'invention concerne des composés de formule (I) qui sont utilisés dans le traitement de maladies caractérisées par l'hyperactivité de la MEK. Selon l'invention, les composés sont utilisés dans le traitement de maladies, telles que le cancer, les troubles du SNC et les troubles cognitifs, ainsi que les maladies inflammatoires/autoimmunes.
Goodnow Robert Alan Jr.
Huby Nicholas John Silvester
Kong Norman
Mcdermott Lee Apostle
Moliterni John Anthony
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Substituted hydantoins for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted hydantoins for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted hydantoins for the treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1773915